19886072

Boda D

2009

Evaluation of 5-alpha reductase activity on cultured fibroblast in patients with hyperandrogenemia.

19887498

Vassilatou E

2010

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.

19887821

Seow KM

2010

Omental fat receptor interacting protein 140 mRNA expression in women with polycystic ovary syndrome.

19888063

ACOG Committee on Practice Bulletins--Gynecology.

2009

ACOG Practice Bulletin No. 108: Polycystic ovary syndrome.

19888409

Steiner CA

2007

Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.

19890022

Banaszewska B

2009

Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial.

19890641

Barber TM

2010

Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging.

19892338

Hamed HO

2010

Metformin versus laparoscopic ovarian drilling in clomiphene- and insulin-resistant women with polycystic ovary syndrome.

19896652

Bhattacharya SM

2010

Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS).

19897327

Tan YY

2010

Gender differences in risk factors for coronary heart disease.

19897682

Magiakou MA

2010

The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.

19900078

Ozdemir S

2010

Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.

19900142

Vanky E

2009

Sex ratio and pregnancy complications according to mode of conception in women with polycystic ovary syndrome.

19902985

Awdishu S

2009

Oligomenorrhoea in exercising women: a polycystic ovarian syndrome phenotype or distinct entity?

19903031

Fan L

2009

Involvement of HSP10 during the ovarian follicular development of polycystic ovary syndrome: Study in both human ovaries and cultured mouse follicles.

19903032

Fanta M

2009

Comparison of corticoid substitution versus combined oral contraception administration in the treatment of non-classic adrenal hyperplasia: a prospective study.

19903035

Milewicz A

2009

The renaissance of metformin in endocrine clinical practice.

19903040

Fruzzetti F

2009

Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome.

19903118

Bhattacharya SM

2010

Insulin resistance and overweight-obese women with polycystic ovary syndrome.

19903344

Colombo O

2009

Dietary intakes in infertile women a pilot study.

19905998

Godoy-Matos AF

2009

Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome.

19905999

Kostrzak A

2009

The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.

19906783

Tan S

2010

Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome.

19906851

Dennedy MC

2010

Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma.

19906888

Tosca L

2010

Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells.

19909585

Polyzos NP

2009

Aromatase inhibitors for female infertility: a systematic review of the literature.

19909589

Guven S

2009

Elevated concentrations of serum ischaemia-modified albumin in PCOS, a novel ischaemia marker of coronary artery disease.

19909598

Garruti G

2009

Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment.

19909600

Cocksedge KA

2009

How common is polycystic ovary syndrome in recurrent miscarriage?

19909601

Seow KM

2009

Omental fat expression of adiponectin and adiponectin receptors in non-obese women with PCOS: a preliminary study.

19909950

Yang Y

2010

Genotype and haplotype determination of interleukin (IL) 1 beta (g. -511C>T and g. +3954C>T) and IL-1RN in polycystic ovary syndrome.

19910321

March WA

2010

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

19913714

Femiano F

2009

An unusual case of oral hirsutism in a patient with polycystic ovarian syndrome.

19913778

Mancini F

2010

Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.

19913856

Wehr E

2010

Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome.

19915773

Merino P

2009

[Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions].

19919014

Chebotareva IuIu

2009

[Modeling of the polycystic ovary syndrome].

19920068

Dickerson EH

2010

Insulin resistance and free androgen index correlate with the outcome of controlled ovarian hyperstimulation in non-PCOS women undergoing IVF.

19921230

Ochsenk?hn R

2010

The effect of nasal oxytocin on pregnancy rates following intrauterine insemination: double-blind, randomized, clinical pilot study.

19923096

Hagym?si K

2009

[Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].

19925815

Salameh WA

2010

Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges.

19926323

Ioannidis A

2010

Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis.

19929617

Sharifi F

2010

Decreased adiponectin levels in polycystic ovary syndrome, independent of body mass index.

19930576

Partsinevelou A

2009

Quality of reporting of randomized controlled trials in polycystic ovary syndrome.

19931073

Morin-Papunen LC

2010

Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: a new etiologic factor in polycystic ovary syndrome?

19931080

Fruzzetti F

2010

Comparison of effects of 3 mg drospirenone plus 20 ?g ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.

19932060

Diamanti-Kandarakis E

2010

PCOS in adolescents.

19932324

Lolis MS

2009

Acne and systemic disease.

19932502

Skrtic A

2011

Immunohistochemical localization of CD31, NOTCH1 and JAGGED1 proteins in experimentally induced polycystic ovaries of immature rats.

19932893

Zhao X

2010

Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome.

19933236

Jedel E

2010

Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index.

19933994

Palomba S

2010

Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome.

19934268

Franchini M

2010

Hemostatic abnormalities in endocrine and metabolic disorders.

19934359

Sir-Petermann T

2010

Effects of birth weight on anti-mullerian hormone serum concentrations in infant girls.

19934376

Malavasi EL

2010

Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levels.

19938957

Liang FJ

2009

Response of IGF and IL-6 to ovarian stimulation in PCOS and normal women.

19939366

Abdalla H

2010

The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation.

19939367

Xu N

2010

Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation.

19939368

Brinton LA

2010

Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome).

19939738

Bruni V

2010

The anorectic and obese adolescent.

19944418

Zakherah MS

2010

Clomiphene citrate plus tamoxifen versus laparoscopic ovarian drilling in women with clomiphene-resistant polycystic ovary syndrome.

19948072

Xu Y

2009

No association of the insulin gene VNTR polymorphism with polycystic ovary syndrome in a Han Chinese population.

19949734

Oh JY

2009

Serum C-reactive protein levels in normal-weight polycystic ovary syndrome.

19950604

Xiong DM

2009

[Autophosphorylation of erythrocyte insulin receptors in patients with polycystic ovary syndrome].

19951139

Verrotti A

2009

Epilepsy, sex hormones and antiepileptic drugs in female patients.

19953938

Zhao JZ

2009

[Outcome of pregnancy in women with polycystic ovary syndrome treated by in vitro maturation of immature oocytes].

19956961

Roy KK

2010

A prospective randomized trial comparing the clinical and endocrinological outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian disease resistant to ovulation induction with clomiphene citrate.

19960891

Glueck CJ

2009

Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.

19963413

Bhattacharya SM

2010

Insulin resistance and adolescent girls with polycystic ovary syndrome.

19965924

Legro RS

2010

Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives.

19966179

Padmanabhan V

2010

Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females.

19995713

Koz?owska A

2009

Expression of steroidogenic enzymes in porcine polycystic ovaries.

19995720

Marciniak A

2009

Leptin concentrations in patients with polycystic ovary syndrome before and after met-formin treatment depending on insulin resistance, body mass index and androgen con-centrations--introductory report.

19996308

Agarwal N

2010

Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial.

19998243

Oppelt PG

2010

The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome.

19999504

Barron AM

2008

Polycystic ovary syndrome in adolescents. A hormonal barrage and metabolic upheaval.

20001571

Kauffman RP

2010

Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role?

20002394

Burt Solorzano CM

2010

Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion.

20002395

Shayya R

2010

Reproductive endocrinology of adolescent polycystic ovary syndrome.

20004371

Thomson RL

2010

Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome.

20004372

Martins WP

2010

Endometrial preparation for in vitro maturation treatment.

20004377

Palomba S

2010

Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes.

20004390

Agdi M

2010

Effects of ovarian puncture for in vitro maturation on subsequent in vitro fertilization cycle in women with polycystic ovaries.

20008514

Barth JH

2010

Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.

20008886

Lainas TG

2010

Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT).

20011085

Prapas N

2009

Genetics of polycystic ovary syndrome.

20011249

Fornes R

2010

Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia.

20012307

Marioli DJ

2010

No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia.

20013429

Aldemir E

2009

[Effects of valproate on male reproductive functions].

20013525

Lippi G

2009

Coagulopathies and thrombosis: usual and unusual causes and associations, Part II.

20013527

Targher G

2009

Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review.

20013528

Mak W

2009

Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis.

20015405

Jin JL

2009

Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women.

20016048

Stener-Victorin E

2010

Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?

20016308

De Cr?e C

2010

Polycystic ovary syndrome and estrogen metabolism in female athletes.

20017329

Hu W

2009

[Characteristics of abnormal glucose tolerance in patients with polycystic ovary syndrome].

20017384

Akhkubekova NK

2009

[Rehabilitation of the patients with polycystic ovary syndrome during sanatorium-and-spa treatment].

20017776

Neal DD

2009

HER LIFESTYLE: a mneumonic for addressing polycystic ovary syndrome in adolescents.

20021712

Pabuccu R

2009

Follicular-fluid anti-Mullerian hormone concentrations are predictive of assisted reproduction outcome in PCOS patients.

20021721

Kaya C

2009

Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS.